These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 20087332)
1. Cognitive factors affect treatment response to medical and psychological treatments in functional bowel disorders. Weinland SR; Morris CB; Dalton C; Hu Y; Whitehead WE; Toner BB; Diamant N; Leserman J; Bangdiwala SI; Drossman DA Am J Gastroenterol; 2010 Jun; 105(6):1397-406. PubMed ID: 20087332 [TBL] [Abstract][Full Text] [Related]
2. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Drossman DA; Toner BB; Whitehead WE; Diamant NE; Dalton CB; Duncan S; Emmott S; Proffitt V; Akman D; Frusciante K; Le T; Meyer K; Bradshaw B; Mikula K; Morris CB; Blackman CJ; Hu Y; Jia H; Li JZ; Koch GG; Bangdiwala SI Gastroenterology; 2003 Jul; 125(1):19-31. PubMed ID: 12851867 [TBL] [Abstract][Full Text] [Related]
3. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Drossman D; Morris CB; Hu Y; Toner BB; Diamant N; Whitehead WE; Dalton CB; Leserman J; Patrick DL; Bangdiwala SI Am J Gastroenterol; 2007 Jul; 102(7):1442-53. PubMed ID: 17509027 [TBL] [Abstract][Full Text] [Related]
4. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage. Halpert A; Dalton CB; Diamant NE; Toner BB; Hu Y; Morris CB; Bangdiwala SI; Whitehead WE; Drossman DA Am J Gastroenterol; 2005 Mar; 100(3):664-71. PubMed ID: 15743366 [TBL] [Abstract][Full Text] [Related]
5. What determines severity among patients with painful functional bowel disorders? Drossman DA; Whitehead WE; Toner BB; Diamant N; Hu YJ; Bangdiwala SI; Jia H Am J Gastroenterol; 2000 Apr; 95(4):974-80. PubMed ID: 10763947 [TBL] [Abstract][Full Text] [Related]
6. The development of a cognitive scale for functional bowel disorders. Toner BB; Stuckless N; Ali A; Downie F; Emmott S; Akman D Psychosom Med; 1998; 60(4):492-7. PubMed ID: 9710296 [TBL] [Abstract][Full Text] [Related]
7. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920 [TBL] [Abstract][Full Text] [Related]
8. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186 [TBL] [Abstract][Full Text] [Related]
9. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Drossman DA; Patrick DL; Whitehead WE; Toner BB; Diamant NE; Hu Y; Jia H; Bangdiwala SI Am J Gastroenterol; 2000 Apr; 95(4):999-1007. PubMed ID: 10763950 [TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in subjects with functional bowel disorders in Germany. Icks A; Haastert B; Enck P; Rathmann W; Giani G Z Gastroenterol; 2002 Oct; 40(10):863-7. PubMed ID: 12436352 [TBL] [Abstract][Full Text] [Related]
11. Prediction of outcome from cognitive-behavioral treatment of irritable bowel syndrome. Blanchard EB; Scharff L; Payne A; Schwarz SP; Suls JM; Malamood H Behav Res Ther; 1992 Nov; 30(6):647-50. PubMed ID: 1417691 [TBL] [Abstract][Full Text] [Related]
12. Cognitive-behavioral group therapy for irritable bowel syndrome: effects and long-term follow-up. van Dulmen AM; Fennis JF; Bleijenberg G Psychosom Med; 1996; 58(5):508-14. PubMed ID: 8902902 [TBL] [Abstract][Full Text] [Related]
14. Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pilot study. Boyce P; Gilchrist J; Talley NJ; Rose D Aust N Z J Psychiatry; 2000 Apr; 34(2):300-9. PubMed ID: 10789535 [TBL] [Abstract][Full Text] [Related]
15. Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Drossman DA; Li Z; Toner BB; Diamant NE; Creed FH; Thompson D; Read NW; Babbs C; Barreiro M; Bank L Dig Dis Sci; 1995 May; 40(5):986-95. PubMed ID: 7729289 [TBL] [Abstract][Full Text] [Related]
17. Not all side effects associated with tricyclic antidepressant therapy are true side effects. Thiwan S; Drossman DA; Morris CB; Dalton C; Toner BB; Diamant NE; Hu JB; Whitehead WE; Leserman J; Bangdiwala SI Clin Gastroenterol Hepatol; 2009 Apr; 7(4):446-51. PubMed ID: 19167522 [TBL] [Abstract][Full Text] [Related]
18. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Heymann-Mönnikes I; Arnold R; Florin I; Herda C; Melfsen S; Mönnikes H Am J Gastroenterol; 2000 Apr; 95(4):981-94. PubMed ID: 10763948 [TBL] [Abstract][Full Text] [Related]
19. Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial. Giosan C; Cobeanu O; Mogoaşe C; Szentagotai A; Mureşan V; Boian R Trials; 2017 May; 18(1):215. PubMed ID: 28494802 [TBL] [Abstract][Full Text] [Related]
20. A biopsychosocial understanding of the irritable bowel syndrome: a review. Goldberg J; Davidson P Can J Psychiatry; 1997 Oct; 42(8):835-40. PubMed ID: 9356771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]